Land: Malaysia
Sprache: Englisch
Quelle: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
CANDESARTAN CILEXETIL
MEDISPEC (M) SDN.BHD
CANDESARTAN CILEXETIL
10x10 Tablets
Unison Laboratories Co. Ltd.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ FINIL 16MG TABLET Candesartan cilexetil (16 mg) 1 WHAT IS IN THIS LEAFLET 1. What Finil 16 is used for 2. How Finil 16 works 3. Before you use Finil 16 4. How to use Finil 16 5. While you are using it 6. Side effects 7. Storage and Disposal of Finil 16 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT FINIL 16 IS USED FOR Finil 16 can be used to: • Treat high blood pressure • Treat heart failure patients with reduced heart muscle function when Angiotensin Converting Enzyme (ACE) inhibitors cannot be used or in addition to ACE- inhibitors. HOW FINIL 16 WORKS Finil 16 contains the active ingredient, Candesartan cilexetil. This belongs to a group of medicines called angiotensin II receptor antagonists. It works by making your blood vessels relax and widen. This helps to lower your blood pressure. It also makes it easier for your heart to pump blood to all parts of your body. BEFORE YOU USE FINIL 16 _- When you must not use it _ • If you are allergic (hypersensitive) to Candesartan cilexetil or any of the other ingredients of this medicine (listed in _Ingredients). _ • If you are more than 3 months pregnant _ _ • If you have severe liver disease or biliary obstruction (a problem with the drainage of the bile from the gall bladder). _ _ • If the patient is a child under 1 year of age. _ _ • If you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing Aliskiren. _ _ _Pregnancy and lactation _ Do not take Finil 16 if you are pregnant, trying to get pregnant or think you may be pregnant. Do not take Finil 16 if you are breast- feeding. Ask your doctor or pharmacist for advice before taking any medicine. _- Before you start to use it _ Talk to your doctor or pharmacist before taking Finil 16. • If you have heart, liver or kidney problems or on dialysis. • If you have recently had a kidney transplant. • If you hav Lesen Sie das vollständige Dokument
-1- -2- -3- The pharmacokinetics of Candesartan cilexetil have not been investigated in pediatric patients < 1 year of age. INDICATION**: • Treatment of hypertension • Treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) as add-on therapy to ACE inhibitors or when ACE inhibitors are not tolerated . DOSAGE AND ADMINISTRATION**: Oral Dosage in Hypertension The recommended initial dose and usual maintenance dose is 8 mg once daily. The dose may be increased to 16 mg once daily. If blood pressure is not sufficiently controlled after 4 weeks of treatment with 16 mg once daily, the dose may be further increased to a maximum of 32 mg once daily (see Pharmacodynamic properties). If blood pressure control is not achieved with this dose, alternative strategies should be considered. Therapy should be adjusted according to blood pressure response. Most of the antihypertensive effect is attained within 4 weeks of initiation of treatment. _USE IN THE ELDERLY_ No initial dosage adjustment is necessary in elderly patients. _USE IN PATIENTS WITH INTRAVASCULAR VOLUME DEPLETION_ An initial dose of 4 mg may be considered in patients at risk for hypotension, such as patients with possible volume depletion (see Warning and precaution). _USE IN IMPAIRED RENAL FUNCTION_ No initial dosage adjustment is necessary in patients with mild to moderate renal impairment (i.e creatinine clearance 30-80 mL/min/1.73 m 2 BSA). In patients with severe renal impairment (i.e. creatinine clearance < 30 mL/min/1.73 m 2 BSA), the clinical experience is limited and a lower initial dose of 4 mg should be considered. _USE IN IMPAIRED HEPATIC FUNCTION_ Patient with hepatic impairment: Dose titration is recommended in patients with mild to moderate chronic liver disease, and a lower initial dose of 4 mg should be considered. Finil 16 should not be used in patients with severe hepatic impairment and/or cholestasis (see Contraindication). _CONCOMITANT THERAPY_ Addition of a thiazi Lesen Sie das vollständige Dokument